CICM examiner reports · fix it Answering a neighbouring question Giving a good answer to a question that was not asked.
What it looks like: The lead-in asks for one thing: the first test, the definitive treatment, the least likely cause, the one most likely diagnosis. A correct answer to a nearby question (the workup instead of the first step, the long-term plan instead of the immediate one) scores nothing.
How to fix it: Read the last line first and underline the qualifier: first, initial, immediate, definitive, least, not, most likely. Say the question back to yourself in your own words before you read the options.
The drill: 15 questions Questions from the Intensive care bank picked because they test this habit. You answer one at a time and see the explanation straight away.
The first 3 are free, below and in the drill with a free account. Any Intensive care plan opens all 15.
Try 3 now. No account needed. Question 1 of 3 Cardiovascular and shock
A 72-year-old woman with long-standing hypertension becomes hypotensive (80/50 mmHg, heart rate 105/min) an hour after mitral valve repair. She is on dobutamine 5 micrograms/kg/min. Transoesophageal echocardiography shows a small, hyperdynamic, hypertrophied left ventricle; in systole the anterior mitral leaflet is displaced into the outflow tract, with a peak outflow gradient of 70 mmHg and a posteriorly directed mitral regurgitant jet. What is the most appropriate immediate management? A Increase dobutamine, give fluid, add milrinone B Stop dobutamine, give fluid, add phenylephrine C Stop dobutamine, give furosemide, add GTN D Stop dobutamine, give fluid, insert a balloon pump
Pick an answer to see the explanation. Next question →
Question 1 of 3 · Cardiovascular and shock
A 72-year-old woman with long-standing hypertension becomes hypotensive (80/50 mmHg, heart rate 105/min) an hour after mitral valve repair. She is on dobutamine 5 micrograms/kg/min. Transoesophageal echocardiography shows a small, hyperdynamic, hypertrophied left ventricle; in systole the anterior mitral leaflet is displaced into the outflow tract, with a peak outflow gradient of 70 mmHg and a posteriorly directed mitral regurgitant jet. What is the most appropriate immediate management?
Increase dobutamine, give fluid, add milrinone Stop dobutamine, give fluid, add phenylephrine Stop dobutamine, give furosemide, add GTN Stop dobutamine, give fluid, insert a balloon pump Show the answer B. Stop dobutamine, give fluid, add phenylephrine
The echocardiographic findings describe systolic anterior motion of the anterior leaflet causing dynamic left ventricular outflow tract obstruction, a recognised complication of mitral repair in a small, hypertrophied ventricle. The obstruction worsens when the ventricle is hyperdynamic, underfilled or ejecting against a low afterload, and with tachycardia. Management is to remove inotropes, fill the ventricle, raise afterload with a pure alpha agonist such as phenylephrine and slow the heart (for example with esmolol). An intra-aortic balloon pump is tempting for post-cardiotomy hypotension, but it lowers afterload and worsens the gradient. Inotropes, diuretics and vasodilators all deepen the obstruction. Persistent obstruction may need surgical revision.
Why not A: Further inotropy and milrinone-induced vasodilation both increase the outflow gradient and the hypotension. Why not C: Diuresis empties the small ventricle and nitrate lowers afterload, both worsening dynamic obstruction. Why not D: Counterpulsation reduces afterload, which increases dynamic outflow obstruction rather than relieving it. Question 2 of 3 · Paediatrics and obstetric critical care
A 1-day-old baby is deeply cyanosed with SpO2 65% despite ventilation on FiO2 1.0. Chest X-ray shows a small heart and diffuse pulmonary oedema. Echocardiography shows infracardiac total anomalous pulmonary venous drainage with obstruction of the descending vein. What is the definitive management?
Alprostadil infusion Inhaled nitric oxide Balloon atrial septostomy alone Emergency surgical repair Show the answer D. Emergency surgical repair
Obstructed total anomalous pulmonary venous drainage is a surgical emergency, because pulmonary venous return cannot reach the heart and the lungs become congested. Drugs that raise pulmonary blood flow, such as nitric oxide, increase pulmonary oedema, and alprostadil gives little benefit. The baby needs urgent surgery, with ECMO as a bridge if needed. It mimics lung disease or PPHN, so echo is essential in a cyanosed newborn. References: AHA Scientific Statement: Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease (2018); AHA/ATS Guidelines: Pediatric Pulmonary Hypertension (2015).
Why not A: Alprostadil does not relieve pulmonary venous obstruction and can worsen pulmonary oedema. Why not B: Raising pulmonary blood flow against an obstructed venous return worsens pulmonary oedema. Why not C: Septostomy does not relieve obstruction of the pulmonary veins themselves. Question 3 of 3 · Sepsis, microbiology and antimicrobials
A 72-year-old woman is on day 3 of treatment for Escherichia coli bacteraemia from a urinary source and has received empirical piperacillin–tazobactam. She has been afebrile for 24 hours, lactate has normalised and creatinine is 82 µmol/L. The isolate is resistant to ampicillin, amoxicillin–clavulanate, ceftriaxone, ciprofloxacin and trimethoprim, and susceptible to piperacillin–tazobactam, gentamicin, meropenem and ceftazidime–avibactam. She has no allergies. What is the most appropriate definitive therapy?
Continue piperacillin–tazobactam Change to meropenem Change to gentamicin Change to ceftazidime–avibactam Add gentamicin to piperacillin–tazobactam Show the answer B. Change to meropenem
Resistance to ceftriaxone in E. coli indicates an extended-spectrum beta-lactamase (or AmpC) producer. The Australian-led MERINO trial randomised patients with ceftriaxone-resistant E. coli or Klebsiella bacteraemia to piperacillin–tazobactam or meropenem and found 30-day mortality of 12.3% versus 3.7%, even though isolates tested susceptible. Clinical improvement on piperacillin–tazobactam is the tempting reason to continue it, but trial patients were also enrolled after empirical therapy, and meropenem remains the definitive agent of choice. Gentamicin is suitable only as short empirical therapy. Ceftazidime–avibactam should be reserved for carbapenem-resistant organisms. Her oral options are excluded by ciprofloxacin and trimethoprim resistance; reassess for step-down if further susceptibilities allow.
Why not A: MERINO found higher 30-day mortality with piperacillin–tazobactam than meropenem for ceftriaxone-resistant E. coli bacteraemia despite in vitro susceptibility. Why not C: Aminoglycoside monotherapy is not recommended as definitive bacteraemia treatment beyond 72 hours when a safer effective agent exists. Why not D: This is a reserve agent for carbapenem-resistant organisms; using it here is poor stewardship with no outcome advantage. Why not E: Combination therapy adds nephrotoxicity and has not been shown to overcome the MERINO mortality signal. Create a free account to save your results and keep going →
Where the CICM examiners flagged it All CICM examiner reports →
Fellowship Ready is not affiliated with or endorsed by the CICM. Not affiliated with the CICM.